Nectar Lifesciences Limited (NSE:NECLIFE)

Nectar Lifesciences Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 23, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	5,104	6,761	3,577	5,393	4,171	2,198
Market Cap Growth	21.24%	89.03%	-33.68%	29.30%	89.80%	-43.19%
Enterprise Value	11,208	13,371	11,331	14,300	11,065	9,063
Last Close Price	22.76	30.15	15.95	24.05	18.60	9.78
PE Ratio	30.60	135.37	-	21.53	-	6.91
PS Ratio	0.30	0.40	0.24	0.32	0.27	0.09
PB Ratio	0.47	0.63	0.34	0.50	0.39	0.19
P/TBV Ratio	0.50	0.67	0.35	0.52	0.41	0.20
P/FCF Ratio	-	3.46	3.45	7.70	-	0.96
P/OCF Ratio	-	3.01	2.68	5.68	19.51	0.77
EV/Sales Ratio	0.67	0.79	0.74	0.86	0.72	0.38
EV/EBITDA Ratio	6.32	8.71	21.00	9.02	10.04	4.12
EV/EBIT Ratio	9.70	14.40	-	14.08	22.14	5.69
EV/FCF Ratio	-	6.85	10.94	20.42	-	3.94
Debt / Equity Ratio	0.58	0.59	0.71	0.79	0.85	0.69
Debt / EBITDA Ratio	3.55	4.14	13.97	5.42	8.19	3.54
Debt / FCF Ratio	-	3.26	7.28	12.28	-	3.38
Asset Turnover	-	0.77	0.67	0.70	0.62	0.89
Inventory Turnover	-	1.59	1.60	1.78	1.39	1.93
Quick Ratio	-	0.45	0.41	0.53	0.38	0.38
Current Ratio	-	1.32	1.38	1.35	1.04	1.29
Return on Equity (ROE)	-	0.47%	-2.25%	2.33%	-6.67%	2.84%
Return on Assets (ROA)	-	2.65%	-0.14%	2.66%	1.24%	3.73%
Return on Capital (ROIC)	4.18%	3.29%	-0.17%	3.25%	1.61%	5.08%
Return on Capital Employed (ROCE)	-	7.60%	-	7.30%	4.20%	11.50%
Earnings Yield	3.33%	0.74%	-6.76%	4.64%	-17.56%	14.46%
FCF Yield	-	28.88%	28.96%	12.98%	-2.36%	104.74%
Dividend Yield	-	-	-	-	-	0.51%
Payout Ratio	-	-	-	-	-	3.53%
Total Shareholder Return	-3.12%	-	-	-	-	0.51%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.